PK//PD/Tolerability Study of DA-1229(Evogliptin) in Renal Impaired Patients

NCT02214693 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Impairment

Interventions

DRUG: DA-1229

Sponsor

Dong-A ST Co., Ltd.